Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / HARP - Harpoon doses first patient in mid-stage cancer trial

HARP - Harpoon doses first patient in mid-stage cancer trial

Harpoon Therapeutics Inc.
  • Harpoon Therapeutics (NASDAQ:HARP) has dosed first patient with HPN536 in a Phase 1/2a clinical trial initially focused on ovarian cancer.
  • More news on: Harpoon Therapeutics, Inc., Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: Harpoon Therapeutics Inc.
Stock Symbol: HARP
Market: NASDAQ
Website: harpoontx.com
Menu
HARP HARP Quote HARP Short HARP News HARP Articles HARP Message Board
Get HARP Alerts

News, Short Squeeze, Breakout and More Instantly...